Clinical Trials Directory

Trials / Completed

CompletedNCT02520596

Absorption and Metabolism of Dietary Phenolics From Raspberries

Bioavailability of Anthocyanins in Humans Following the Ingestion of Berries and Grapes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Parma · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Red raspberries are a rich source of (poly)phenolic compounds, the main components being anthocyanins and ellagitannins. There is growing evidence linking consumption of these compounds with beneficial effects on human health. However, the mechanisms involved remain poorly understood principally because of a limited understanding of the bioavailability of ellagitannins and anthocyanins. This study aims to explore the identity and amounts of the phenolic metabolites of anthocyanins and ellagitannins in human plasma and urine following acute ingestion of raspberries. For this purpose ten healthy volunteers were feed 300 g of blended raspberries containing in total 293 μmol anthocyanins and 250 μmol ellagitannins. All urine excreted over 48 h after the ingestion of raspberries was collected and blood samples were collected before (0 h) and after raspberry consumption up to 24 h. Metabolites were identified and quantified by ultra high performance liquid chromatography-mass spectrometry (UHPLC-MS).

Conditions

Interventions

TypeNameDescription
OTHERBioavailability of Raspberry polyphenols

Timeline

Start date
2013-11-01
Primary completion
2014-03-01
Completion
2014-06-01
First posted
2015-08-13
Last updated
2015-08-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02520596. Inclusion in this directory is not an endorsement.